, 208:201 | Cite as

Are attention lapses related to d-amphetamine liking?

  • Michael McCloskeyEmail author
  • Abraham A. Palmer
  • Harriet de Wit
Original Investigation



A rich literature suggests that both impulsiveness and drug-induced euphoria are risk factors for drug abuse. However, few studies have examined whether sensitivity to the euphoric effects of stimulants is related to attention lapses, a behavioral measure of inattention sometimes associated with impulsivity.


The aim of the study was to examine ratings of d-amphetamine drug liking among individuals with high, moderate, and low attention lapses.


Ninety-nine healthy volunteers were divided into three equal-sized groups based on their performance on a measure of lapses of attention. The groups, who exhibited low, medium, and high attention lapses (i.e., long reaction times) on a simple reaction time task, were compared on their subjective responses (i.e., ratings of liking and wanting more drug) after acute doses of d-amphetamine (0, 5, 10, and 20 mg).


Subjects who exhibited high lapses liked 20 mg d-amphetamine less than subjects who exhibited low lapses. These subjects also tended to report smaller increases in “wanting more drug” after d-amphetamine.


The findings suggest that participants who exhibit impaired attention may be less sensitive to stimulant-induced euphoria.


Inattention d-amphetamine Reward Drug liking Subjective effects Dopamine Impulsiveness 



The authors thank Margo Meverden and Adam Strohm for their technical contributions.


  1. APA (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, D.CGoogle Scholar
  2. Arns M, de Ridder S, Strehl U, Breteler M, Coenen A (2009) Efficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis. Clin EEG Neurosci 40:180–189PubMedGoogle Scholar
  3. Baler RD, Volkow ND (2006) Drug addiction: the neurobiology of disrupted self-control. Trends Mol Med 12:559–566CrossRefPubMedGoogle Scholar
  4. Belin D, Mar AC, Dalley JW, Robbins TW, Everitt BJ (2008) High impulsivity predicts the switch to compulsive cocaine-taking. Science 320:1352–1355CrossRefPubMedGoogle Scholar
  5. Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D et al (2000) Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs 32(Suppl: i–iv):1–112Google Scholar
  6. Castellanos FX, Tannock R (2002) Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 3:617–628PubMedGoogle Scholar
  7. Castellanos FX, Sonuga-Barke EJ, Milham MP, Tannock R (2006) Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci 10:117–123CrossRefPubMedGoogle Scholar
  8. Conners CK (2002) Forty years of methylphenidate treatment in attention-deficit/hyperactivity disorder. J Atten Disord 6(Suppl 1):S17–S30PubMedGoogle Scholar
  9. de Wit H (2009) Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol 14:22–31CrossRefPubMedGoogle Scholar
  10. de Wit H, Phan KL (2009) Positive reinforcement theories of drug use. In: Kassel JD (ed) Substance abuse and emotion. American Psychological Association, Washington, D.CGoogle Scholar
  11. Wade TR, de Wit H, Richards JB (2000) Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats. Psychopharmacology (Berl) 150:90–101CrossRefGoogle Scholar
  12. de Wit H, Richards JB (2004) Dual determinants of drug abuse: reward and impulsivity. In: Bevins RA, Bardo MT (eds) Nebraska symposium on motivation. University of Nebraska Press, Nebraska, pp 19–55Google Scholar
  13. de Wit H, Pierri J, Johanson CE (1989) Reinforcing and subjective effects of diazepam in nondrug-abusing volunteers. Pharmacol Biochem Behav 33:205–213CrossRefGoogle Scholar
  14. de Wit H, Crean J, Richards JB (2000) Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behav Neurosci 114:830–837CrossRefPubMedGoogle Scholar
  15. de Wit H, Enggasser JL, Richards JB (2002) Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 27:813–825CrossRefPubMedGoogle Scholar
  16. Everitt BJ, Belin D, Economidou D, Pelloux Y, Dalley JW, Robbins TW (2008) Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 363:3125–3135CrossRefPubMedGoogle Scholar
  17. Gambin M, Swiecicka M (2009) Relation between response inhibition and symptoms of inattention and hyperactivity–impulsivity in children. Br J Clin Psychol 48:425–430CrossRefPubMedGoogle Scholar
  18. Gevensleben H, Holl B, Albrecht B, Vogel C, Schlamp D, Kratz O et al (2009) Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial. J Child Psychol Psychiatry Allied Discipl 50:780–789CrossRefGoogle Scholar
  19. Girden ER (1992) ANOVA repeated measures, vol 84. Sage, Newbury ParkGoogle Scholar
  20. Greenhill L, Beyer DH, Finkleson J, Shaffer D, Biederman J, Conners CK et al (2002) Guidelines and algorithms for the use of methylphenidate in children with attention-deficit/hyperactivity disorder. J Atten Disord 6(Suppl 1):S89–S100PubMedGoogle Scholar
  21. Hausknecht KA, Acheson A, Farrar AM, Kieres AK, Shen RY, Richards JB et al (2005) Prenatal alcohol exposure causes attention deficits in male rats. Behav Neurosci 119:302–310CrossRefPubMedGoogle Scholar
  22. Iacono WG, Malone SM, McGue M (2008) Behavioral disinhibition and the development of early-onset addiction: common and specific influences. Annu Rev Clin Psychol 4:325–348CrossRefPubMedGoogle Scholar
  23. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715–723CrossRefPubMedGoogle Scholar
  24. Leth-Steensen C, Elbaz Z, Douglas V (2000) Mean response times, variability and skew in the responding of ADHD children: a response time distributional approach. Acta Psychol (Amst) 104:167–190CrossRefGoogle Scholar
  25. Leyton M, aan het Rot M, Booij L, Baker GB, Young SN, Benkelfat C (2007) Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion. J Psychiatry Neurosci 32:129–136PubMedGoogle Scholar
  26. Lott DC, Kim SJ, Cook EH Jr, de Wit H (2005) Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 30:602–609CrossRefPubMedGoogle Scholar
  27. McNair D, Lorr M, Droppleman L (1971) Manual for the profile of mood states (manual). Educational and Industrial Service, San DiegoGoogle Scholar
  28. Munro CA, McCaul ME, Oswald LM, Wong DF, Zhou Y, Brasic J et al (2006) Striatal dopamine release and family history of alcoholism. Alcohol Clin Exp Res 30:1143–1151CrossRefPubMedGoogle Scholar
  29. Oswald LM, Wong DF, McCaul M, Zhou Y, Kuwabara H, Choi L et al (2005) Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacology 30:821–832PubMedGoogle Scholar
  30. Oswald LM, Wong DF, Zhou Y, Kumar A, Brasic J, Alexander M et al (2007) Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release. Neuroimage 36:153–166CrossRefPubMedGoogle Scholar
  31. Patrick CJ, Curtin JJ, Tellegen A (2002) Development and validation of a brief form of the multidimensional personality questionnaire. Psychol Assess 14:150–163CrossRefPubMedGoogle Scholar
  32. Patton JH, Stanford MS, Barratt ES (1995) Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51:768–774CrossRefPubMedGoogle Scholar
  33. Perry JL, Nelson SE, Carroll ME (2008) Impulsive choice as a predictor of acquisition of IV cocaine self- administration and reinstatement of cocaine-seeking behavior in male and female rats. Exp Clin Psychopharmacol 16:165–177CrossRefPubMedGoogle Scholar
  34. Poulos CX, Parker JL, Le DA (1998) Increased impulsivity after injected alcohol predicts later alcohol consumption in rats: evidence for “loss-of-control drinking” and marked individual differences. Behav Neurosci 112:1247–1257CrossRefPubMedGoogle Scholar
  35. Reeves DL, Bleiberg J, Roebuck-Spencer T, Cernich AN, Schwab K, Ivins B et al (2006) Reference values for performance on the automated neuropsychological assessment metrics V3.0 in an active duty military sample. Mil Med 171:982–994PubMedGoogle Scholar
  36. Reynolds B, Ortengren A, Richards JB, de Wit H (2006) Dimensions of impulsive behavior: personality and behavioral measures. Pers Individ Differ 40:305–315CrossRefGoogle Scholar
  37. Rosa-Neto P, Lou HC, Cumming P, Pryds O, Karrebaek H, Lunding J et al (2005) Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage 25:868–876CrossRefPubMedGoogle Scholar
  38. Scheres A, Milham MP, Knutson B, Castellanos FX (2007) Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/hyperactivity disorder. Biol Psychiatry 61:720–724CrossRefPubMedGoogle Scholar
  39. Simmonds DJ, Fotedar SG, Suskauer SJ, Pekar JJ, Denckla MB, Mostofsky SH (2007) Functional brain correlates of response time variability in children. Neuropsychologia 45:2147–2157CrossRefPubMedGoogle Scholar
  40. Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R (2006) Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 28:266–279CrossRefPubMedGoogle Scholar
  41. Spencer SV, Hawk LW Jr, Richards JB, Shiels K, Pelham WE Jr, Waxmonsky JG (2009) Stimulant treatment reduces lapses in attention among children with ADHD: the effects of methylphenidate on intra-individual response time distributions. J Abnorm Child Psychol 37:805–816CrossRefPubMedGoogle Scholar
  42. Tarter RE, Kirisci L, Mezzich A, Cornelius JR, Pajer K, Vanyukov M et al (2003) Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am J Psychiatry 160:1078–1085CrossRefPubMedGoogle Scholar
  43. van Gaalen MM, van Koten R, Schoffelmeer AN, Vanderschuren LJ (2006) Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry 60:66–73CrossRefPubMedGoogle Scholar
  44. Ventura R, Cabib S, Alcaro A, Orsini C, Puglisi-Allegra S (2003) Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. J Neurosci 23:1879–1885PubMedGoogle Scholar
  45. Walderhaug E, Lunde H, Nordvik JE, Landro NI, Refsum H, Magnusson A (2002) Lowering of serotonin by rapid tryptophan depletion increases impulsiveness in normal individuals. Psychopharmacology (Berl) 164:385–391CrossRefGoogle Scholar
  46. White TL, Justice AJ, de Wit H (2002) Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav 73:729–741CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Michael McCloskey
    • 1
    • 2
    Email author
  • Abraham A. Palmer
    • 2
    • 3
  • Harriet de Wit
    • 2
  1. 1.Department of PsychologyTemple UniversityPhiladelphiaUSA
  2. 2.Department of Psychiatry and Behavioral NeuroscienceUniversity of ChicagoChicagoUSA
  3. 3.Department of Human GeneticsUniversity of ChicagoChicagoUSA

Personalised recommendations